Eli Lilly and Co (LLY.US) weight loss drug breakthrough! Research shows that tirzepatide can significantly reduce the risk of heart failure.
eli lilly and co's flagship weight loss drug Zepbound and diabetes treatment drug Mounjaro's active ingredient Tirzepatide can significantly reduce the risk of worsening heart failure in obese adults with heart failure with preserved ejection fraction (HFpEF).
Express News | Astrazeneca, eli lilly and co, and other funds have invested in Chengyuan Technology.
Weight-reducing version of semaglutide lands in the Chinese market! Novo Nordisk (NVO.US) unlocks new growth engine.
novo-nordisk a/s launched Wegovy in china at a price lower than in the usa; this is an important step for the company to increase its investment in the rapidly growing market in china.
Trading volume TOP20 | Cryptocurrency concept stocks rise, microstrategy up nearly 13%, Coinbase gains 6.4%.
On Monday, the highest trading volume in US stocks was Tesla, which rose by 5.62%, with a turnover of 42.916 billion USD; sixth place was palantir, which fell by 6.86%, with a turnover of 8.412 billion USD; twelfth place was super micro computer, which rose by 15.93%, with a turnover of 3.952 billion USD.
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Eli Lilly and Co Options Spot-On: On November 18th, 107.32K Contracts Were Traded, With 373.69K Open Interest
On November 18th ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 107.32K options for the day, of which put options accounted for 51.26% of the total